Table 1.
Study | Design | n. of pts | Technique | Failure% | Starting crit. | Failure pred. |
Duca et al. | Retrospective | 85 | hCPAP (71); NPPV (7); IMV (7) | 88,5% Deaths: 76.5% |
PaO2< 60, RR>30 in NRB mask |
age > 60 |
Alviset et al. | Retrospective | 49 | Mask CPAP | 53% Deaths: 36% |
SpO < 90% in NRB mask |
Low basal PaO2 |
Di Domenico et. Al. | Retrospective | 90 (27 DNI) |
CPAP/NPPV | 57% Deaths: 47% 89% in DNI |
SpO2 < 90% or < 94% on O2 12- 15 l/min |
Low basal PaO2/FiO2 ratio |
Franco et al. | Prospective | 670 | 163 HFNC, 330 hCPAP, 177 NPPV | 30% Deaths: 30% |
SpO2 < 94% RR > 20 poor response to O2 15 L/min | Age, n. of comorbidities, Low PaO2/FiO2 |
Nightingale et al. | Retrospective | 24 | Mask CPAP | 38% | Type 1 AHRF | Age, n. of comorbidities |
Burns et al. | Retrospective | 28 (DNI) | Mask CPAP (23) NPPV (5) |
Deaths: 50% | SpO2 < 94% In O2 40% |
«Typical» aspect on CXR |
Bellani et al | Prospective | 909 | CPAP 85% (mainly via helmet), NPPV 10%; HFNC 5% | 37,6% | n.r. | Lower PaO2/FiO2 ratio; higher CRP; platelet count |